Feedback / Questions
FB418 - 1ST Bio
FB-101 - 1ST Bio, D&D Pharmatech
https://www.globenewswire.com/news-release/2022/10/18/2536020/0/en/1ST-Biotherapeutics-Inc-Announces-Positive-Phase-I-Data-of-c-Abl-Inhibitor-in-Neurodegeneration.html
Oct 18, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next